Hypothermic therapy device shows promise in treating concussions

TecTraum Inc. announced complete enrollment status for a clinical trial evaluating its pro2cool device, a noninvasive hypothermic therapy system for treating concussions.
The device, designed to decrease the severity of concussion symptoms, provides localized cooling for the head and neck to lower blood temperature before reaching the brain, the company stated in a press release.
According to the CDC, as many as 3.8 million sports and recreation-related concussions occur annually in the United States. In addition, from 2001 to 2012, emergency room visits doubled among children with concussions.

TecTraum Inc. announced complete enrollment status for a clinical trial evaluating its pro2cool device, a noninvasive hypothermic therapy system for treating concussions.
The device, designed to decrease the severity of concussion symptoms, provides localized cooling for the head and neck to lower blood temperature before reaching the brain, the company stated in a press release.
According to the CDC, as many as 3.8 million sports and recreation-related concussions occur annually in the United States. In addition, from 2001 to 2012, emergency room visits doubled among children with concussions.